191 related articles for article (PubMed ID: 4044058)
1. Lung colonization and metastasis by disseminated B16 melanoma cells: H-2 associated control at the level of the host and the tumor cell.
Taniguchi K; Kärre K; Klein G
Int J Cancer; 1985 Oct; 36(4):503-10. PubMed ID: 4044058
[TBL] [Abstract][Full Text] [Related]
2. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes.
Kawano Y; Taniguchi K; Toshitani A; Nomoto K
J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664
[TBL] [Abstract][Full Text] [Related]
3. Host H-2 genotype regulates the metastatic ability of H-2-associated variants of B16 melanoma: defense systems screening for absence of self H-2 components by natural killer cells and host-associated homing barrier.
Kawano Y; Taniguchi K; Kärre K; Toshitani A; Nomoto K
Cell Immunol; 1988 Feb; 111(2):341-53. PubMed ID: 3338095
[TBL] [Abstract][Full Text] [Related]
4. Anti-metastatic effect by in vivo administration of concanavalin A through augmentation of T-derived activated killer activity: efficacy to B16 melanoma expressed MHC antigen.
Taniguchi K; Kawano YI; Toshitani A; Karashima A; Nomoto K
Cell Immunol; 1989 May; 120(2):460-9. PubMed ID: 2785862
[TBL] [Abstract][Full Text] [Related]
5. Impaired H-2 expression in B16 melanoma variants.
Nanni P; Colombo MP; De Giovanni C; Lollini PL; Nicoletti G; Parmiani G; Prodi G
J Immunogenet; 1983 Oct; 10(5):361-70. PubMed ID: 6644070
[TBL] [Abstract][Full Text] [Related]
6. Interferon-mediated enhancement of metastasis. Are MHC antigens involved?
Lollini PL; De Giovanni C; Del Re B; Nicoletti G; Prodi G; Nanni P
Clin Exp Metastasis; 1987; 5(4):277-87. PubMed ID: 3117468
[TBL] [Abstract][Full Text] [Related]
7. Interferon-induced alterations in metastatic capacity, class-1 antigen expression and natural killer cell sensitivity of melanoma cells.
McMillan TJ; Rao J; Everett CA; Hart IR
Int J Cancer; 1987 Nov; 40(5):659-63. PubMed ID: 2445702
[TBL] [Abstract][Full Text] [Related]
8. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
9. Growth and metastasis in allogeneic hosts. Lack of H-2-negative or somatic hybrid variant selection.
De Giovanni C; Lollini PL; Nicoletti G; Del Re B; Scotlandi K; Prodi G; Nanni P
Exp Clin Immunogenet; 1987; 4(3):153-62. PubMed ID: 3273420
[TBL] [Abstract][Full Text] [Related]
10. TNF impairs in vivo and in vitro natural killer (NK) susceptibility of B16 melanoma cells.
Palmieri G; Morrone S; Lollini PL; De Giovanni C; Nicoletti G; Nanni P; Frati L; Santoni A
Scand J Immunol; 1992 Mar; 35(3):279-87. PubMed ID: 1535986
[TBL] [Abstract][Full Text] [Related]
11. Inverse relationship in H-2-associated lysis between NK cells and rIL-2-activated killer cells: evidence from in vitro killing and metastatic experiments.
Toshitani A; Taniguchi K; Kawano Y; Nomoto K
Cell Immunol; 1987 Aug; 108(1):188-202. PubMed ID: 3496972
[TBL] [Abstract][Full Text] [Related]
12. Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.
Gorelik E; Wiltrout RH; Brunda MJ; Bere WE; Herberman RB
Clin Exp Metastasis; 1985; 3(2):111-23. PubMed ID: 4042460
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of intravascular mouse melanoma dissemination by recombinant human interferon alpha A/D.
Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
Jpn J Cancer Res; 1986 Jan; 77(1):80-4. PubMed ID: 3082819
[TBL] [Abstract][Full Text] [Related]
14. Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon.
Ueda M; Mishima Y; Mojamdar M; Ichihashi M; Kita M; Kishida T
Arch Dermatol Res; 1986; 278(4):329-34. PubMed ID: 3740943
[TBL] [Abstract][Full Text] [Related]
15. Restoration by recombinant interferon alpha A/D of host defense systems against tumor in immunosuppressed mice.
Nishimura J; Mitsui K; Tanaka Y; Yamamoto R; Suhara Y; Ishitsuka H
Clin Exp Metastasis; 1986; 4(1):35-44. PubMed ID: 3698367
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of metastatic potential by gamma-interferon.
Kelly SA; Gschmeissner S; East N; Balkwill FR
Cancer Res; 1991 Aug; 51(15):4020-7. PubMed ID: 1906780
[TBL] [Abstract][Full Text] [Related]
17. IFN-treatment of B16-F1 versus B16-F10: relative impact on non-adaptive and T-cell-mediated immune defense in metastatic spread.
Zöller M
Clin Exp Metastasis; 1988; 6(5):411-29. PubMed ID: 3132343
[TBL] [Abstract][Full Text] [Related]
18. Antimetastatic effect of defibrinogenation with batroxobin depends on the natural killer activity of host in mice.
Shibuya M; Niitani H; Aoyama A; Kawachi S; Nukariya N; Baba M; Iizuka K; Sakai S; Ohtsuka M
J Cancer Res Clin Oncol; 1990; 116(2):168-72. PubMed ID: 2324160
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth and pulmonary metastasis of B16-F10 murine melanoma by N-1554, a polyprenyl phosphate.
Okamoto Y; Ohwaki T; Kawase S; Ishii Y; Hongyo T; Tahara Y; Mishima Y
Cancer Lett; 1991 May; 57(2):159-63. PubMed ID: 2025888
[TBL] [Abstract][Full Text] [Related]
20. Effects of the immunomodulator LS 2616 on growth and metastasis of the murine B16-F10 melanoma.
Kalland T
Cancer Res; 1986 Jun; 46(6):3018-22. PubMed ID: 3486041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
